Disease Activity and remission Archives

Abstract Number: 2448 • ACR/ARP Annual Meeting 2019
Factors Associated with Discordance Between Patient and Rheumatologist Assessment of Disease Activity in Psoriatic Arthritis Considered in Remission
Marie Moly¹, Cédric Lukas ², Jacques Morel ¹, Bernard Combe ³ and Gaël Mouterde ⁴, ¹CHU Montpellier, Montpellier, France, ²Rheumatology department, CHU Montpellier, Univ Montpellier, Montpellier, France, ³CHU Montpellier, Montpellier University, Montpellier, France, ⁴CHU Montpellier and Univ Montpellier, Montpellier, France
Background/Purpose: Assessment of disease activity in psoriatic arthritis (PsA) requires evaluation of multiple aspects and can be difficult. Perception of disease activity by patient and…
Abstract Number: 1713 • ACR/ARHP Annual Meeting 2018
Attainment of Low Disease Activity and Remission in SLE Patients Who Started with High Disease Activity in the Atacicept Phase IIb Address II Study and Its Long-Term Extension
Eric Morand¹, Joan T. Merrill², David A. Isenberg³, Amy H. Kao⁴, Cristina Vazquez-Mateo⁴, Stephen Wax⁵, Peter Chang⁵, Kishore Pudota⁴, Cynthia Aranow⁶ and Daniel J. Wallace⁷, ¹Monash University, Melbourne, Australia, ²Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ³University College London, London, United Kingdom, ⁴EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, ⁵EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), BIllerica, MA, ⁶The Feinstein Institute for Medical Research, Manhasset, NY, ⁷Cedars-Sinai Medical Center/David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA
Background/Purpose: Low disease activity (LDA) and remission are important goals in the treatment of patients (pts) with SLE.1,2 Lupus Low Disease Activity State (LLDAS) is…

Abstracts tagged "Disease Activity and remission"

Factors Associated with Discordance Between Patient and Rheumatologist Assessment of Disease Activity in Psoriatic Arthritis Considered in Remission

Attainment of Low Disease Activity and Remission in SLE Patients Who Started with High Disease Activity in the Atacicept Phase IIb Address II Study and Its Long-Term Extension